All WMO research is subject to a number of requirements connected to the positive opinion obtained. Among other things, this concerns notification to the reviewing committee of the end of the study in the Netherlands. If the study has been terminated early, you must state the reason for this. You can use the CCMO form Notification end of study for this purpose. 

For research with a medicinal product, in addition to the form Notification end of study, you must also submit the EudraCT end of trial form to the reviewing committee.

In case of international research you must also report the global end of study date, if it is different from the end date in the Netherlands. For research with a medicinal product, you must use the EudraCT end of trial form for this.

Download

B6. MREC form Notification end of study

B7. EudraCT end of trial form

^{Participating institutions: UMC Utrecht, Prinses Máxima Centrum for pediatric oncology and Antoni van Leeuwenhoek}